As of Apr 26, 2024, the Gilead Sciences stock's PE ratio is 14.41. This results from the current EPS of $4.54 and stock price of $65.42. The P/E ratio has a decrease of 18% from the past four quarters average of 17.5.
The PE ratio of Gilead Sciences has averaged 39.45 over the last ten years. The current PE ratio of 14.41 is 63% below the historical average. Over the past ten years, GILD's PE ratio was at its highest in the Dec 2020 quarter at 582.6, when the stock price was $58.26 and the EPS was $0.1. The lowest value was in the Dec 2016 quarter, when it reached 7.1 with a price of $71.61 and an EPS of $10.08.
Maximum annual increase: 3,700.39% in 2020
Maximum annual decrease: -97.49% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 17.84 | -23.96% |
| 2022 | 23.46 | 60.25% |
| 2021 | 14.64 | -97.49% |
| 2020 | 582.6 | 3,700.39% |
| 2019 | 15.33 | 2.96% |
| 2018 | 14.89 | -26.43% |
| 2017 | 20.24 | 185.07% |
| 2016 | 7.1 | -13.2% |
| 2015 | 8.18 | -31.03% |
| 2014 | 11.86 | -68.25% |
The current PE ratio of GILD is below the 3, 5 and 10-year averages.
Compared to its peers LLY and MRK, GILD's PE ratio stands lower, however it is higher than JNJ's. Gilead Sciences's PE ratio is trading below the peer group average of 35.26.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.53 | $352.02B |
| GILD Gilead Sciences Inc | 14.41 | $81.5B |
| AMGN Amgen Inc | 21.5 | $144.69B |
| BIIB Biogen Inc | 25.95 | $30.42B |
| VRTX Vertex Pharmaceuticals Inc | 28.29 | $102.67B |
| ABBV AbbVie Inc | 58.47 | $281.96B |
| PFE Pfizer Inc | 66.84 | $143.43B |
| LLY ELI LILLY & Co | 126.03 | $696.96B |
| MRK Merck & Co Inc | 937.14 | $332.28B |
| ILMN Illumina Inc | N/A | $19.43B |
GILD stock has a price to earnings ratio of 14.41 as of Apr 26, 2024.
Over the last 3 years, the average price to earnings ratio for GILD stock is 17.72.
Over the last 5 years, the average price to earnings ratio for GILD stock is 65.52.
In the last ten years, the Dec 2020 quarter recorded the highest quarterly PE ratio at 582.6.
GILD's price to earnings ratio is currently 63% below its 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 26, 2024), Gilead Sciences's stock price is $65.42. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $4.54. Therefore, Gilead Sciences's P/E ratio for today is 14.41. PE RATIO(14.41) = STOCK PRICE($65.42) / TTM EPS($4.54)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.